Veri
ExitedThe Veri (literally translated as blood in Finnish) wearable device provides users with a simple and effective way of tracking their blood sugar levels. The ultimate goal here is achieving optimal metabolic health, i.e. preventative medicine.
Veri has raised €3.3M across 1 funding round from 5 investors, most recently a Seed round in Jun 2021. Based in Helsinki, Finland; active in Healthtech. Acquired by ŌURA in 2024. Data as of 28 Oct 2026.
Helsinki, Finlandwww.veristable.com ↗
Total raised
€3.3M
€3,288,933
Funding rounds
1
Investors
5
distinct backers
Active since
2021-06
latest 2021-06
Funding by year
EUR raised per yearVeri — funding by year — interactive chart.
Data table
| Veri — funding by year | |
|---|---|
| 2021 | €3.3M |
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-06-07 | Seed | €3.3M | Accel,Johannes Schildt,Kristian Ranta,Lifeline Ventures,PROfounders Capital | View deal → |
Exit
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData